OpenURL Connection Search

Select item for more details and to access through your institution.

Dynamics of tumor in situ fluid circulating tumor DNA in recurrent glioblastomas forecasts treatment efficacy of immune checkpoint blockade coupled with low-dose bevacizumab.
Published in:
Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 10, p. 1, doi. 10.1007/s00432-024-05997-8
By:
- Wang, Dayang;
- Zhang, Jiubing;
- Bu, Chaojie;
- Liu, Guanzheng;
- Guo, Guangzhong;
- Zhang, Ziyue;
- Lv, Guangming;
- Sheng, Zhiyuan;
- Yan, Zhaoyue;
- Gao, Yvshuai;
- Wang, Meiyun;
- Liu, Gang;
- Zhao, Ruijiao;
- Li, Tianxiao;
- Ma, Chunxiao;
- Bu, Xingyao
Publication type:
Article
Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cellfree tumor DNA from tumor in situ fluid.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1238607
By:
- Zhiyuan Sheng;
- Chaojie Bu;
- Jie Mei;
- Sensen Xu;
- Ziyue Zhang;
- Guangzhong Guo;
- Yushuai Gao;
- Liyuan Xing;
- Zhongcan Chen;
- Juha Hernesniemi;
- Ajmal Zemmar;
- Xingyao Bu
Publication type:
Article
Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03774-7
By:
- Guo, Guangzhong;
- Zhang, Ziyue;
- Zhang, Jiubing;
- Wang, Dayang;
- Xu, Sensen;
- Liu, Guanzheng;
- Gao, Yushuai;
- Mei, Jie;
- Yan, Zhaoyue;
- Zhao, Ruijiao;
- Wang, Meiyun;
- Li, Tianxiao;
- Bu, Xingyao
Publication type:
Article
Genomic alterations of oligodendrogliomas at distant recurrence.
Published in:
Cancer Medicine, 2023, v. 12, n. 16, p. 17171, doi. 10.1002/cam4.6327
By:
- Liu, Guanzheng;
- Bu, Chaojie;
- Guo, Guangzhong;
- Zhang, Zhiyue;
- Sheng, Zhiyuan;
- Deng, Kaiyuan;
- Wu, Shuang;
- Xu, Sensen;
- Bu, Yage;
- Gao, Yushuai;
- Wang, Meiyun;
- Liu, Gang;
- Kong, Lingfei;
- Li, Tianxiao;
- Li, Ming;
- Bu, Xingyao
Publication type:
Article
Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment.
Published in:
Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.956
By:
- Xu, Sensen;
- Sheng, Zhiyuan;
- Yu, Jinliang;
- Deng, Kaiyuan;
- Wu, Shuang;
- Bu, Yage;
- Guo, Guangzhong;
- Zhang, Ziyue;
- Liu, Guanzheng;
- Gao, Yushuai;
- Yan, Zhaoyue;
- Bu, Chaojie;
- He, Yingkun;
- Liu, Gang;
- Zemmar, Ajmal;
- Hernesniemi, Juha;
- Kong, Lingfei;
- Wang, Meiyun;
- Li, Tianxiao;
- Bu, Xingyao
Publication type:
Article
RESPONSES OF SINGLE OLFACTORY RECEPTOR CELL TO SEX PHEROMONES IN MALE MOTH PARANTHRENE TABANZFORMIS.
Published in:
Insect Science, 1995, v. 2, n. 2, p. 130, doi. 10.1111/j.1744-7917.1995.tb00034.x
By:
- Wu, Caihong;
- Guo, Guangzhong;
- Liu, Hanqian;
- Lin, Guoqiang
Publication type:
Article

Found: 6

Dynamics of tumor in situ fluid circulating tumor DNA in recurrent glioblastomas forecasts treatment efficacy of immune checkpoint blockade coupled with low-dose bevacizumab.

Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cellfree tumor DNA from tumor in situ fluid.

Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis.

Genomic alterations of oligodendrogliomas at distant recurrence.

Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment.

RESPONSES OF SINGLE OLFACTORY RECEPTOR CELL TO SEX PHEROMONES IN MALE MOTH PARANTHRENE TABANZFORMIS.